You can buy or sell PRTC and other stocks, options, and ETFs commission-free!
PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others.
52 Week High
52 Week Low
— per share
Expected May 24, Pre-Market